Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 4 opinions in the last 12 months.
Becton Dickinson (BDX-N) is a leading player in the medical disposables market, holding a significant 25% market share and a market capitalization over $60 billion. The company faced challenges during the COVID-19 pandemic, particularly with the postponement of elective surgeries, resulting in a temporary decline in revenues. However, growth is now rebounding, with projections indicating annual growth of 8-10% and the potential for double-digit earnings growth by the end of 2024. Analysts are optimistic, noting the company's strong cash flow, ongoing acquisition opportunities, and share buyback initiatives. Despite its lackluster stock performance, many experts find it compelling and believe it is positioned for future growth.
With a market cap of over $60 billion it is the largest player in the medical disposables sector with 25% market share. Growth stalled for two years during COVID but is accelerating now. Its profits are solid so there is lots of room for acquisitions and a start to buying back shares. Trades at 17X earnings and there should be double digit earnings growth ahead. Can be somewhat volatile. Buy 16 Hold 2 Sell 0
(Analysts’ price target is $281.00)Becton Dickinson is a American stock, trading under the symbol BDX-N on the New York Stock Exchange (BDX). It is usually referred to as NYSE:BDX or BDX-N
In the last year, 6 stock analysts published opinions about BDX-N. 2 analysts recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Becton Dickinson.
Becton Dickinson was recommended as a Top Pick by on . Read the latest stock experts ratings for Becton Dickinson.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
6 stock analysts on Stockchase covered Becton Dickinson In the last year. It is a trending stock that is worth watching.
On 2025-05-02, Becton Dickinson (BDX-N) stock closed at a price of $168.78.
They just reported a disappointing quarter, plunging shares 18%. Many are giving up on it, but it's a buying opportunity. For decades, this was a reliable growth stock, but in the past 5 years have been sideways. They reported beats and raises last year. They sold their life sciences division to unlock value, a smart move. But at the same time, they issued mixed guidance, including slightly lower earnings due to tariffs; they said they would have made their guidance if not for the tariffs. Trades at a low 12x this year's estimates and have bought back many shares already this year.